# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001829126-25-004535
Filing Date
2025-06-17
Accepted
2025-06-17 06:00:32
Documents
3
Period of Report
2025-07-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nexalintech_def14a.htm | DEF 14A | 177140
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 709947
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 444300
| Complete submission text file | 0001829126-25-004535.txt |  | 1672554

Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41507 | Film No.: 251051752
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)